Insights

Innovative Therapeutics Chugai Pharmaceutical's focus on developing novel therapies for age-related diseases presents a significant opportunity to offer specialized solutions and technologies that support advanced drug discovery and personalized medicine approaches.

Strategic Acquisitions The company's planned acquisition of Renalys Pharma indicates a willingness to expand its portfolio and capabilities, creating potential avenues for partnership, licensing, and supply chain collaborations in renal and related therapeutic areas.

AI-Driven Development Chugai's partnership with SoftBank to leverage generative AI for drug development offers a unique opportunity to provide AI-enabled data analytics, automation tools, or cloud solutions that enhance research efficiency and reduce clinical trial costs.

Collaborative Research Ongoing joint research efforts with biotech firms like Gero for antibody development for age-related conditions highlight potential for supplying specialized biologics, manufacturing services, or research collaborations to accelerate their pipeline.

Market Presence Being listed on Japan's Prime Market and targeting unmet medical needs positions Chugai to be receptive to innovative healthcare solutions from global vendors, providing opportunities to introduce advanced diagnostics, treatment devices, or patient engagement tools.

中外製薬 / Chugai Pharmaceutical Co., Ltd. Tech Stack

中外製薬 / Chugai Pharmaceutical Co., Ltd. uses 8 technology products and services including AWS Lambda, Power BI, Jenkins, and more. Explore 中外製薬 / Chugai Pharmaceutical Co., Ltd.'s tech stack below.

  • AWS Lambda
    Big Data Processing
  • Power BI
    Business Intelligence
  • Jenkins
    Continuous Integration
  • SQL
    Database
  • DocuSign
    Miscellaneous
  • Windows Server
    Operating Systems
  • Android
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

中外製薬 / Chugai Pharmaceutical Co., Ltd.'s Email Address Formats

中外製薬 / Chugai Pharmaceutical Co., Ltd. uses at least 1 format(s):
中外製薬 / Chugai Pharmaceutical Co., Ltd. Email FormatsExamplePercentage
First.Last@chugai-pharm.co.jpJohn.Doe@chugai-pharm.co.jp
75%
FirstLast@chugai-pharm.co.jpJohnDoe@chugai-pharm.co.jp
21%
Last.First@chugai-pharm.co.jpDoe.John@chugai-pharm.co.jp
3%
FirstLas@chugai-pharm.co.jpJohnDoe@chugai-pharm.co.jp
1%

Frequently Asked Questions

Where is 中外製薬 / Chugai Pharmaceutical Co., Ltd.'s headquarters located?

Minus sign iconPlus sign icon
中外製薬 / Chugai Pharmaceutical Co., Ltd.'s main headquarters is located at 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo 1038324, JP. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is 中外製薬 / Chugai Pharmaceutical Co., Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
中外製薬 / Chugai Pharmaceutical Co., Ltd.'s official website is chugai-pharm.co.jp and has social profiles on LinkedIn.

What is 中外製薬 / Chugai Pharmaceutical Co., Ltd.'s NAICS code?

Minus sign iconPlus sign icon
中外製薬 / Chugai Pharmaceutical Co., Ltd.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does 中外製薬 / Chugai Pharmaceutical Co., Ltd. have currently?

Minus sign iconPlus sign icon
As of October 2025, 中外製薬 / Chugai Pharmaceutical Co., Ltd. has approximately 5K employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Head Of Innovation Antenna - Special Assignment For Japan: M. S.Head Of Platform Service Group(it Infrastructure): D. Y.Head Of Digital Transformation Unit, Associate Vice President / Dxユニット長、参与: T. S.. Explore 中外製薬 / Chugai Pharmaceutical Co., Ltd.'s employee directory with LeadIQ.

What industry does 中外製薬 / Chugai Pharmaceutical Co., Ltd. belong to?

Minus sign iconPlus sign icon
中外製薬 / Chugai Pharmaceutical Co., Ltd. operates in the Pharmaceutical Manufacturing industry.

What technology does 中外製薬 / Chugai Pharmaceutical Co., Ltd. use?

Minus sign iconPlus sign icon
中外製薬 / Chugai Pharmaceutical Co., Ltd.'s tech stack includes AWS LambdaPower BIJenkinsSQLDocuSignWindows ServerAndroidX-Content-Type-Options.

What is 中外製薬 / Chugai Pharmaceutical Co., Ltd.'s email format?

Minus sign iconPlus sign icon
中外製薬 / Chugai Pharmaceutical Co., Ltd.'s email format typically follows the pattern of First.Last@chugai-pharm.co.jp. Find more 中外製薬 / Chugai Pharmaceutical Co., Ltd. email formats with LeadIQ.

中外製薬 / Chugai Pharmaceutical Co., Ltd.

Pharmaceutical ManufacturingJapan5001-10000 Employees

Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/

Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html


中外製薬(本社:東京)は、抗体エンジニアリング技術をはじめ独自の創薬技術基盤を強みとする、研究開発型の製薬企業です。ロシュ・グループの重要なメンバーであるとともに、東京証券取引所プライム市場の上場企業として、自主独立経営の下、アンメットメディカルニーズを満たす革新的な医薬品の創製に取り組んでいます。

ご利用にあたってはソーシャルメディアポリシーをご覧ください:
https://www.chugai-pharm.co.jp/rule/sns/index.html

Section iconCompany Overview

Headquarters
1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo 1038324, JP
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
5001-10000

Section iconFunding & Financials

  • $250M$500M

    中外製薬 / Chugai Pharmaceutical Co., Ltd.'s revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    中外製薬 / Chugai Pharmaceutical Co., Ltd.'s revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.